Author:
Weiss G.J.,Bemis L.T.,Nakajima E.,Sugita M.,Birks D.K.,Robinson W.A.,Varella-Garcia M.,Bunn P.A.,Haney J.,Helfrich B.A.,Kato H.,Hirsch F.R.,Franklin W.A.
Reference26 articles.
1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006
2. From radiotherapy to targeted therapy: 20 years in the management of non-small-cell lung cancer;Weiss;Oncology (Williston Park),2006
3. Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa', ZD1839) in non-small-cell lung cancer;Parra;Br J Cancer,2004
4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004
5. Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization—why, when, and how?;Dziadziuszko;Clin Cancer Res,2006
Cited by
203 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献